Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
S.M. Rowe, S. Miller, E.J. Sorscher.
Mechanisms of disease: cystic fibrosis.
N Engl J Med, 352 (2005), pp. 1992-2001
[2.]
B.C. Marshall, S.M. Butler, M. Stoddard, A.M. Moran, T.G. Liou, W.J. Morgan.
Epidemiology of Cystic Fibrosis-related Diabetes.
J Pediatr, 146 (2005), pp. 681-687
[3.]
S. Lang, B. Thorsteinsson, J. Nerup, C. Koch.
Diabetes mellitus in cystic fibrosis: a ten year prospective study.
Diabetologia, 43 (2000), pp. 107A
[4.]
C.E. Milla, W.J. Warwick, A. Moran.
Trends in pulmonary function in patients with Cystic Fibrosis correlate with the degree of glucose intolerance at baseline.
Am J Respir Crit Care Med, 162 (2000), pp. 891-895
[5.]
S. Tofé, J.C. Moreno, M. Alonso, H. Escobar, R. Barrio.
Insulinsecretion abnormalities and clinical deterioration related to impaired glucose tolerance in Cystic Fibrosis.
Eur J Endocrinol, 152 (2005), pp. 1-8
[6.]
R. Barrio, E. García, C. Gómez-Canadela, M. Gussinyé, J.F. Merino, M.T. Muñoz.
Conferencia de consenso: despistaje, diagnóstico y tratamiento de la diabetes relacionada con Fibrosis Quística.
An Esp Pediatría, 53 (2002), pp. 573-579
[7.]
C. Mueller-Brandes, R.W. Holl, M. Nastoll, M. Ballmann.
New criteria for impaired fasting glucose and screening for diabetes in Cystic Fibrosis.
Eur Respir J, 25 (2005), pp. 715-717
[8.]
F. Lombardi, V. Raia, M.I. Spagnuolo, R. Nugnes, G. Valerio, G. Ciccarelli, et al.
Diabetes in an infant with cystic fibrosis.
Pediatr Diabetes, 5 (2004), pp. 199-201
[9.]
C. Polychronakos.
Early onset diabetes mellitus. Tip or iceberg?.
Pediatric Diabetes, 5 (2004), pp. 171-173
[10.]
A.L. Brennan, D.M. Geddes, K.M. Gyi, E.H. Baker.
Clinical importance of Cystic Fibrosis-related Diabetes.
J Cystic Fibrosis, 3 (2004), pp. 209-222
[11.]
F. Lombardo, F. De Luca, M. Rosano, C. Sferlazzas, C. Lucanto, T. Arrigo, et al.
Natural history of glucose tolerance, beta-cell function and peripheral insulin sensitivity in cystic fibrosis patients with fasting euglycemia.
Eur J Endocrinol, 149 (2003), pp. 53-59
[12.]
A. Moran, K.L. Pyzdrowski, J. Weinreb, B.B. Kahn, S.A. Smith, K.S. Adams, et al.
Insulin sensitivity in cystic fibrosis.
Diabetes, 43 (1994), pp. 1020-1026
[13.]
D.S. Hardin, A. LeBlanc, S. Lukenbaugh, D.K. Seilheimer.
Insulin resistance is associated with decreased clinical status in Cystic Fibrosis.
J Pediatr, 130 (1997), pp. 948-956
[14.]
D.S. Hardin, A. LeBlanc, G. Marshall, D.K. Seilheimer.
Mechanisms of insulin resistance in cystic fibrosis.
Am J Physiol Endocrinol Metab, 281 (2001), pp. E1022-E1028
[15.]
A.D.R. Mackie, S.J. Thornton, F.P. Edenborough.
Cystc fibrosisrelated diabetes.
Diabetic Medicine, 20 (2003), pp. 425-436
[16.]
E.J. Sims, M.W. Green, A. Methta.
Decreased lung function in female but not male subjects with established cystic fibrosis-related diabetes.
Diabetes Care, 28 (2005), pp. 1581-1587
[17.]
M. Rafii, K. Chapman, C. Stewart, E. Kelly, A. Hanna, D.C. Wilson, et al.
Changes in response to insulin and the effects of varying glucose tolerance on whole-body protein metabolism in patients with cystic fibrosis.
Am J Clin Nutr, 81 (2005), pp. 421-426
[18.]
A. Moran, R. Basu, C. Mill, M.D. Jensen.
Insulin regulation of free fatty acid kinetics in adult Cystic Fibrosis patients with impaired glucose tolerance.
Metabolism, 53 (2004), pp. 1467-1472
[19.]
L. Dobson, A.T. Hattersley, S. Tiley, S. Elworthy, P.J. Oades, C.D. Sheldon.
Clinical improvement in cystic fibrosis with early insulin treatment.
Arch Dis Child, 82 (2002), pp. 430-431
Copyright © 2006. Sociedad Española de Endocrinología y Nutrición